Occudo Quantitative Strategies’s Aclaris Therapeutics ACRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-13,504
| Closed | -$14.2K | – | 708 |
|
|
2023
Q4 | $14.2K | Buy |
+13,504
| New | +$14.2K | ﹤0.01% | 745 |
|
|
2022
Q3 | – | Sell |
-11,799
| Closed | -$165K | – | 1141 |
|
|
2022
Q2 | $165K | Buy |
11,799
+33
| +0.3% | +$461 | 0.01% | 952 |
|
|
2022
Q1 | $203K | Sell |
11,766
-9,377
| -44% | -$162K | 0.02% | 940 |
|
|
2021
Q4 | $307K | Sell |
21,143
-6,172
| -23% | -$89.6K | 0.03% | 754 |
|
|
2021
Q3 | $492K | Buy |
27,315
+6,949
| +34% | +$125K | 0.06% | 548 |
|
|
2021
Q2 | $358K | Buy |
20,366
+7,323
| +56% | +$129K | 0.05% | 530 |
|
|
2021
Q1 | $329K | Buy |
+13,043
| New | +$329K | 0.07% | 460 |
|